Results for
"[search-keyword]"
Sponsor content
229 result(s) found, displaying 1 to 10
- AusPAR: GavretoAustralian Public Assessment Report (AusPAR)AusPAR for GAVRETO (pralsetinib) for treatment of locally advanced or metastatic RET fusion-positive non-small cell lung cancer.
- Roche Products Pty Ltd - Specimen receptacle IVDs (425682)ARTGAustralian Register of Therapeutic Goods (ARTG) information for Roche Products Pty Ltd - Specimen receptacle IVDs.
- Vabysmo Roche Products Pty LtdOct-2023Prescription medicine evaluationActive ingredient: faricimab.
- ColumviPrescription medicine decision summaryColumvi (glofitamab) is provisionally approved to treat adult patients with relapsed or refractory diffuse large B-cell lymphoma (DLBCL)
- COLUMVI glofitamab (rch) 10 mg/10 mL concentrated solution for infusion vial (392331)ARTGAustralian Register of Therapeutic Goods (ARTG) information for COLUMVI glofitamab (rch) 10 mg/10 mL concentrated solution for infusion vial.
- COLUMVI glofitamab (rch) 2.5 mg/2.5 mL concentrated solution for infusion vial (389650)ARTGAustralian Register of Therapeutic Goods (ARTG) information for COLUMVI glofitamab (rch) 2.5 mg/2.5 mL concentrated solution for infusion vial.
- GAZYVA (Roche Products Pty Ltd)Prescription medicine registrationActive ingredients: obinutuzumab.
- XOFLUZA baloxavir marboxil 80 mg film-coated tablet blister pack (388092)ARTGAustralian Register of Therapeutic Goods (ARTG) information for XOFLUZA baloxavir marboxil 80 mg film-coated tablet blister pack.